Diagnosing prostate cancer at a curable stage means providing PSA tests to asymptomatic patients
Bradley and colleagues’ editorial1 reiterates outdated uncertainties around prostate specific antigen (PSA) based screening for prostate cancer and fails to highlight advances in UK clinical…
